RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lang Wu to Cell Line, Tumor

This is a "connection" page, showing publications Lang Wu has written about Cell Line, Tumor.
Connection Strength

0.081
  1. Wang S, Wang J, Lu X, Liu M, Liu Y, Li M, Kong X, Wu L, Guan Q, Zhang W. Design, synthesis and biological evaluation of novel tubulin-targeting agents with a dual-mechanism for polymerization inhibition and protein degradation. Eur J Med Chem. 2024 Jun 05; 272:116458.
    View in: PubMed
    Score: 0.037
  2. Shi L, Yang Y, Li M, Li C, Zhou Z, Tang G, Wu L, Yao Y, Shen X, Hou Z, Jia H. LncRNA IFITM4P promotes immune escape by up-regulating PD-L1 via dual mechanism in oral carcinogenesis. Mol Ther. 2022 04 06; 30(4):1564-1577.
    View in: PubMed
    Score: 0.032
  3. Zhang L, Zhang WG, Ma EL, Wu L, Bao K, Wang XL, Wang YL, Song HR. Synthesis and antiproliferative in-vitro activity of natural flavans and related compounds. Arch Pharm (Weinheim). 2007 Dec; 340(12):650-5.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support